Skip to content
Pierre Country
    • Homepage
Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026

Author: MARINA MAHER COMMUNICATIONS

Posted Date:

May 20, 2026
  • Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026

    MARINA MAHER COMMUNICATIONS
    May 20, 2026
  • Ronald McDonald House Announces First-Ever Global Spokesfamily

    MARINA MAHER COMMUNICATIONS
    May 15, 2026
  • College Football Comes to the Boricua Stage

    MARINA MAHER COMMUNICATIONS
    May 8, 2026
  • ELAI Expands into the United States, Appoints Former Prudential Global Chief Data Officer as CEO, North America

    MARINA MAHER COMMUNICATIONS
    April 29, 2026
  • New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

    MARINA MAHER COMMUNICATIONS
    April 10, 2026
  • Discover Puerto Rico Launches “Awaken Your Senses,” A Global Campaign Built on Consumer Psychology and Sensory Travel

    MARINA MAHER COMMUNICATIONS
    March 10, 2026
  • Eisai and Advocacy Leaders Launch “Kompass,” a Digital Destination to Help Patients and Caregivers Navigate the Complexities of Kidney Cancer

    MARINA MAHER COMMUNICATIONS
    February 26, 2026
  • Women’s Health, Sports & Performance Institute Launches as First-of-Its-Kind Organization for Female Athletes

    MARINA MAHER COMMUNICATIONS
    January 29, 2026